Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03949049

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Neonatal Hypoxia Asphyxia Neonatorum Congenital, Hereditary, and Neonatal Diseases and Abnormalities Infant, Newborn, Diseases

Age range

Up to 1 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

About this study

Efficacy of Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • neonates with hypoxia.

Exclusion criteria

  • hypoxic ischemic encephalopathy

Treatment and study plan

Citicoline

Drug

Citacoline as neuroprotector

Other names: citacoline

Placebo

Other

placebo group

Primary outcomes

  1. number of seizures

    Time frame: 6 months

Study contacts

Contact information is provided by the study sponsor or research team.

sherief abd-elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Efficacy of Citicoline as Neuroprotector in Neonates Exposed to Hypoxia: A Randomized Controlled Trial

Important dates

Study start
2019
Primary completion
2029
Study completion
2029
First posted
May 14, 2019
Registry last updated
May 29, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.